NCT00208455 A Multi-centre Study to Assess the Long-term Performance of the DePuy PROXIMA™ Hip in Primary Total Hip Replacement Status TERMINATED Phase PHASE4
NCT00208429 A Multi-centre Study to Assess the Long-term Performance of the Pinnacle™ Cup With a Polyethylene-on-metal Bearing in Primary Total Hip Replacement Status WITHDRAWN Phase PHASE4
NCT00208390 A Multi-centre Study to Assess the Long-term Performance of the Summit™ Hip in Primary Total Hip Replacement Status TERMINATED Phase PHASE4
NCT00208377 A Multi-centre Study to Assess the Long-term Performance of the DePuy ASR™ System in Primary Hip Resurfacing Surgery Status TERMINATED Phase PHASE4
NCT00208364 A Two Centre Study to Assess the Long-term Performance of the Pinnacle™ Cup With a Metal-on-Metal Bearing in Primary Total Hip Replacement Status TERMINATED Phase PHASE4
NCT00207714 An Efficacy and Safety Study of CNTO 148 Subcutaneous Injection Compared With Placebo in Patients With Active Rheumatoid Arthritis Status COMPLETED Phase PHASE2
NCT00205478 Phase 2 Clinical Study in Rheumatoid Arthritis With an Investigational Oral p38 MAP Kinase Inhibitor VX-702 Status COMPLETED Phase PHASE2
NCT00195702 Efficacy and Safety of Adalimumab in Patients With Active Rheumatoid Arthritis Treated Concomitantly With Methotrexate. Status COMPLETED Phase PHASE3
NCT00195494 Study Comparing Etanercept and Methotrexate vs. Methotrexate Alone in Rheumatoid Arthritis Status COMPLETED Phase PHASE4
NCT00195403 A Drug Use Investigation of ENBREL for Post-marketing Surveillance (PMS) for RA and PsA Status COMPLETED Phase N/A
NCT00195364 Study Evaluating Etanercept in Patients With Rheumatoid Arthritis Who Completed Trial 0881A1-301-EU in Spain Status COMPLETED Phase N/A
NCT00195338 Study Evaluating Enbrel In Adults With Active Rheumatoid Arthritis In Luxemburg Status COMPLETED Phase N/A
NCT00175877 A Study of the Safety and Effectiveness of Lyophilized Certolizumab Pegol in the Treatment of Signs and Symptoms of Rheumatoid Arthritis and in Prevention of Joint Damage in Patients With Active Rheumatoid Arthritis Status COMPLETED Phase PHASE3
NCT00172666 Decoy Receptor 3 (DcR3) Polymorphisms in Rheumatoid Arthritis (RA) and Systemic Lupus Erythematosus (SLE) Status UNKNOWN Phase N/A
NCT00170872 6 Week Open-label Trial With Lumiracoxib 200mg o.d. in Primary Knee Osteoarthritis or Rheumatoid Arthritis Status COMPLETED Phase PHASE3
NCT00162292 Multiple Ascending Dose Study of BMS-582949 in Patients With Stable Rheumatoid Arthritis on the Methotrexate Background Status COMPLETED Phase PHASE1